Interobserver and Intraobserver Agreement on the Treatment of Infantile Hemangiomas
The results of this survey study suggest that there is an important variability in the treatment of intermediate-risk and low-risk IH. The study findings support the need for more evidence regarding the role of topical timolol in IH treatment, which may help harmonize treatment approaches and improve consistency in IH management globally.
Authors
- J. del Boz-González
- Ricardo Ruíz‐Villaverde (ORCID: https://orcid.org/0000-0002-0381-6174)
- M.Á. Descalzo (ORCID: https://orcid.org/0000-0002-2262-7547)
- Mercè Grau‐Pérez (ORCID: https://orcid.org/0000-0002-7628-3495)
- I. García‐Doval (ORCID: https://orcid.org/0000-0002-6881-5260)
- Maria Colmenero‐Sendra
- Eulàlia Baselga Torres
Institutions
- Hospital Sant Joan de Déu Barcelona (ES)
- Universidad de Granada (ES)
- Hospital Costa del Sol (ES)
- Spanish Academy of Dermatology and Venereology (ES)
- Hospital Universitario Puerta de Hierro Majadahonda (ES)
- Hospital Regional Universitario de Málaga (ES)
- Instituto de Investigación Biosanitaria de Granada (ES)
Publication Details
- Journal
- JAMA Dermatology
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1001/jamadermatol.2024.5125
- Citations
- 2
- Primary Topic
- Vascular Malformations and Hemangiomas
- Type
- article
- Field-Weighted Citation Impact
- 1.15